Literature DB >> 29584889

Longitudinal Assessment of Illnesses, Stress Dosing, and Illness Sequelae in Patients With Congenital Adrenal Hyperplasia.

Diala El-Maouche1, Courtney J Hargreaves1, Ninet Sinaii2, Ashwini Mallappa1, Padmasree Veeraraghavan1, Deborah P Merke1,3.   

Abstract

Context: Patients with congenital adrenal hyperplasia (CAH) are at risk for life-threatening adrenal crises. Management of illness episodes aims to prevent adrenal crises. Objective: We evaluated rates of illnesses and associated factors in patients with CAH followed prospectively and receiving repeated glucocorticoid stress dosing education.
Methods: Longitudinal analysis of 156 patients with CAH followed at the National Institutes of Health Clinical Center over 23 years was performed. The rates of illnesses and stress-dose days, emergency room (ER) visits, hospitalizations, and adrenal crises were analyzed in relation to phenotype, age, sex, treatment, and hormonal evaluations.
Results: A total of 2298 visits were evaluated. Patients were followed for 9.3 ± 6.0 years. During childhood, there were more illness episodes and stress dosing than adulthood (P < 0.001); however, more ER visits and hospitalizations occurred during adulthood (P ≤ 0.03). The most robust predictors of stress dosing were young age, low hydrocortisone and high fludrocortisone dose during childhood, and female sex during adulthood. Gastrointestinal and upper respiratory tract infections (URIs) were the two most common precipitating events for adrenal crises and hospitalizations across all ages. Adrenal crisis with probable hypoglycemia occurred in 11 pediatric patients (ages 1.1 to 11.3 years). Undetectable epinephrine was associated with ER visits during childhood (P = 0.03) and illness episodes during adulthood (P = 0.03). Conclusions: Repeated stress-related glucocorticoid dosing teaching is essential, but revised age-appropriate guidelines for the management of infectious illnesses are needed for patients with adrenal insufficiency that aim to reduce adrenal crises and prevent hypoglycemia, particularly in children.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29584889      PMCID: PMC6276663          DOI: 10.1210/jc.2018-00208

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  35 in total

1.  Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families.

Authors:  Radha Nandagopal; Ninet Sinaii; Nilo A Avila; Carol Van Ryzin; Wuyan Chen; Gabriela P Finkielstain; Sneha P Mehta; Nazli B McDonnell; Deborah P Merke
Journal:  Eur J Endocrinol       Date:  2011-03-28       Impact factor: 6.664

2.  Adrenal crisis in treated Addison's disease: a predictable but under-managed event.

Authors:  Katherine White; Wiebke Arlt
Journal:  Eur J Endocrinol       Date:  2009-09-23       Impact factor: 6.664

3.  Exploring Inpatient Hospitalizations and Morbidity in Patients With Adrenal Insufficiency.

Authors:  Paul M Stewart; Beverly M K Biller; Claudio Marelli; Candace Gunnarsson; Michael P Ryan; Gudmundur Johannsson
Journal:  J Clin Endocrinol Metab       Date:  2016-09-13       Impact factor: 5.958

4.  A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia.

Authors:  Aikaterini A Nella; Ashwini Mallappa; Ashley F Perritt; Verena Gounden; Parag Kumar; Ninet Sinaii; Lori-Ann Daley; Alexander Ling; Chia-Ying Liu; Steven J Soldin; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2016-09-28       Impact factor: 5.958

5.  A glucocorticoid education group meeting: an effective strategy for improving self-management to prevent adrenal crisis.

Authors:  Han J W J Repping-Wuts; Nike M M L Stikkelbroeck; Alida Noordzij; Mies Kerstens; Ad R M M Hermus
Journal:  Eur J Endocrinol       Date:  2013-05-17       Impact factor: 6.664

Review 6.  Management of adolescents with congenital adrenal hyperplasia.

Authors:  Deborah P Merke; Dix P Poppas
Journal:  Lancet Diabetes Endocrinol       Date:  2013-11-15       Impact factor: 32.069

7.  Presentation, acute illness, and learning difficulties in salt wasting 21-hydroxylase deficiency.

Authors:  M D Donaldson; P H Thomas; J G Love; G D Murray; A W McNinch; D C Savage
Journal:  Arch Dis Child       Date:  1994-03       Impact factor: 3.791

Review 8.  Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Stefan R Bornstein; Bruno Allolio; Wiebke Arlt; Andreas Barthel; Andrew Don-Wauchope; Gary D Hammer; Eystein S Husebye; Deborah P Merke; M Hassan Murad; Constantine A Stratakis; David J Torpy
Journal:  J Clin Endocrinol Metab       Date:  2016-01-13       Impact factor: 5.958

9.  A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia.

Authors:  Ashwini Mallappa; Ninet Sinaii; Parag Kumar; Martin J Whitaker; Lori-Ann Daley; Dena Digweed; David J A Eckland; Carol Van Ryzin; Lynnette K Nieman; Wiebke Arlt; Richard J Ross; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2014-12-11       Impact factor: 5.958

10.  Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort.

Authors:  Nils Krone; Ian T Rose; Debbie S Willis; James Hodson; Sarah H Wild; Emma J Doherty; Stefanie Hahner; Silvia Parajes; Roland H Stimson; Thang S Han; Paul V Carroll; Gerry S Conway; Brian R Walker; Fiona MacDonald; Richard J Ross; Wiebke Arlt
Journal:  J Clin Endocrinol Metab       Date:  2013-01-21       Impact factor: 5.958

View more
  18 in total

Review 1.  The way toward adulthood for females with nonclassic congenital adrenal hyperplasia.

Authors:  Georgia Ntali; Sokratis Charisis; Christo F Kylafi; Evangelia Vogiatzi; Lina Michala
Journal:  Endocrine       Date:  2021-04-14       Impact factor: 3.633

Review 2.  Adrenal insufficiency.

Authors:  Stefanie Hahner; Richard J Ross; Wiebke Arlt; Irina Bancos; Stephanie Burger-Stritt; David J Torpy; Eystein S Husebye; Marcus Quinkler
Journal:  Nat Rev Dis Primers       Date:  2021-03-11       Impact factor: 52.329

3.  Low Adrenomedullary Function Predicts Acute Illness in Infants With Classical Congenital Adrenal Hyperplasia.

Authors:  Jonathan Weber; Veeraya K Tanawattanacharoen; Amy Seagroves; Mark C Liang; Christina M Koppin; Heather M Ross; Tania A S S Bachega; Mitchell E Geffner; Monica Serrano-Gonzalez; Gagandeep Bhullar; Mimi S Kim
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 6.134

4.  Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision).

Authors:  Tomohiro Ishii; Kenichi Kashimada; Naoko Amano; Kei Takasawa; Akari Nakamura-Utsunomiya; Shuichi Yatsuga; Tokuo Mukai; Shinobu Ida; Mitsuhisa Isobe; Masaru Fukushi; Hiroyuki Satoh; Kaoru Yoshino; Michio Otsuki; Takuyuki Katabami; Toshihiro Tajima
Journal:  Clin Pediatr Endocrinol       Date:  2022-04-10

5.  Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Phyllis W Speiser; Wiebke Arlt; Richard J Auchus; Laurence S Baskin; Gerard S Conway; Deborah P Merke; Heino F L Meyer-Bahlburg; Walter L Miller; M Hassan Murad; Sharon E Oberfield; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

Review 6.  Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

Authors:  Hedi L Claahsen-van der Grinten; Phyllis W Speiser; S Faisal Ahmed; Wiebke Arlt; Richard J Auchus; Henrik Falhammar; Christa E Flück; Leonardo Guasti; Angela Huebner; Barbara B M Kortmann; Nils Krone; Deborah P Merke; Walter L Miller; Anna Nordenström; Nicole Reisch; David E Sandberg; Nike M M L Stikkelbroeck; Philippe Touraine; Agustini Utari; Stefan A Wudy; Perrin C White
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

Review 7.  Management challenges and therapeutic advances in congenital adrenal hyperplasia.

Authors:  Ashwini Mallappa; Deborah P Merke
Journal:  Nat Rev Endocrinol       Date:  2022-04-11       Impact factor: 47.564

Review 8.  The Impact of SARS-Cov-2 Virus Infection on the Endocrine System.

Authors:  Noel Pratheepan Somasundaram; Ishara Ranathunga; Vithiya Ratnasamy; Piyumi Sachindra Alwis Wijewickrama; Harsha Anuruddhika Dissanayake; Nilukshana Yogendranathan; Kavinga Kalhari Kobawaka Gamage; Nipun Lakshitha de Silva; Manilka Sumanatilleke; Prasad Katulanda; Ashley Barry Grossman
Journal:  J Endocr Soc       Date:  2020-07-02

Review 9.  The Role of International Databases in Understanding the Aetiology and Consequences of Differences/Disorders of Sex Development.

Authors:  Salma Rashid Ali; Angela Lucas-Herald; Jillian Bryce; Syed Faisal Ahmed
Journal:  Int J Mol Sci       Date:  2019-09-07       Impact factor: 5.923

10.  A Prospective Study of Children Aged 0-8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules.

Authors:  Uta Neumann; Katarina Braune; Martin J Whitaker; Susanna Wiegand; Heiko Krude; John Porter; Dena Digweed; Bernard Voet; Richard J M Ross; Oliver Blankenstein
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.